BIOCURE TECHNOLOGY INC. Cash Flow Conversion Efficiency

Latest as of December 2025: -0.005x

BIOCURE TECHNOLOGY INC. cash flow conversion efficiency. Based on the latest financial reports, BIOCURE TECHNOLOGY INC. (1WH) has a cash flow conversion efficiency ratio of -0.005x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-8.28K ≈ $-9.68K USD) by net assets (€1.58 Million ≈ $1.84 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is BIOCURE TECHNOLOGY INC. worth for the company's overall valuation and market capitalisation.

Cash Flow Conversion Efficiency of BIOCURE TECHNOLOGY INC. (2021–2025)

Cash flow conversion efficiency of BIOCURE TECHNOLOGY INC. from 2021 to 2025. This chart illustrates how BIOCURE TECHNOLOGY INC.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View 1WH live share price for real-time trading data and today's change.

BIOCURE TECHNOLOGY INC. Cash Flow Conversion Ratio Explained

BIOCURE TECHNOLOGY INC. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

BIOCURE TECHNOLOGY INC. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BIOCURE TECHNOLOGY INC. ranked by their cash flow conversion efficiency. Review free cash flow generation of BIOCURE TECHNOLOGY INC. to assess how much free cash flow the company generates relative to operating cash flow.

Company	Cash Flow Conversion Efficiency
Rare Foods Australia Ltd AU:RFA	-0.026x
Li Bang International Corporation Inc. Ordinary Shares NASDAQ:LBGJ	-0.040x
International Frontier Resources Corporation V:IFR	0.017x
James Cropper PLC LSE:CRPR	0.161x
Lifeist Wellness Inc V:LFST	-0.325x
Marwyn Value Investors Limited LSE:MVI	0.017x
Identillect Technologies Corp V:ID	0.006x
Tearlach Resources Ltd V:TEA	-0.043x

Annual Cash Flow Conversion Efficiency for BIOCURE TECHNOLOGY INC. (2021–2025)

The table below shows the annual cash flow conversion efficiency of BIOCURE TECHNOLOGY INC. from 2021 to 2025. Also see BIOCURE TECHNOLOGY INC. asset portfolio for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€1.58 Million ≈ $1.84 Million	€-76.52K ≈ $-89.46K	-0.049x	-574.70%
2024-12-31	€1.34 Million ≈ $1.57 Million	€13.71K ≈ $16.03K	0.010x	+107.55%
2023-12-31	€1.60 Million ≈ $1.87 Million	€-217.13K ≈ $-253.84K	-0.135x	-138.52%
2022-12-31	€-2.33 Million ≈ $-2.72 Million	€-818.38K ≈ $-956.77K	0.352x	-72.34%
2021-12-31	€-852.32K ≈ $-996.45K	€-1.08 Million ≈ $-1.27 Million	1.271x	--

About BIOCURE TECHNOLOGY INC.

F:1WH Germany Biotechnology

Market Cap

$2.80 Million

€2.40 Million EUR

Market Cap Rank

#30717 Global

#2683 in Germany

Share Price

€0.03

Change (1 day)

+21.43%

52-Week Range

€0.02 - €0.03

All Time High

€1.65